2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis

医学 肉芽肿伴多发性血管炎 嗜酸性 内科学 痹症科 显微镜下多血管炎 血管炎 抗中性粒细胞胞浆抗体 病理 疾病
作者
Peter C. Grayson,Cristina Ponte,Ravi Suppiah,Joanna Robson,Anthea Craven,Andrew Judge,Sara Khalid,Andrew Hutchings,Raashid Luqmani,Richard A. Watts,Peter A. Merkel,Paul Gatenby,Catherine Hill,Dwarakanathan Ranganathan,Andreas Kronbichler,Daniel Blockmans,Lillian Barra,Simon Carette,Christian Pagnoux,Navjot Dhindsa
出处
期刊:Annals of the Rheumatic Diseases [BMJ]
卷期号:81 (3): 309-314 被引量:517
标识
DOI:10.1136/annrheumdis-2021-221794
摘要

To develop and validate revised classification criteria for eosinophilic granulomatosis with polyangiitis (EGPA).Patients with vasculitis or comparator diseases were recruited into an international cohort. The study proceeded in five phases: (1) identification of candidate criteria items using consensus methodology, (2) prospective collection of candidate items present at the time of diagnosis, (3) data-driven reduction of the number of candidate items, (4) expert panel review of cases to define the reference diagnosis and (5) derivation of a points-based risk score for disease classification in a development set using least absolute shrinkage and selection operator logistic regression, with subsequent validation of performance characteristics in an independent set of cases and comparators.The development set for EGPA consisted of 107 cases of EGPA and 450 comparators. The validation set consisted of an additional 119 cases of EGPA and 437 comparators. From 91 candidate items, regression analysis identified 11 items for EPGA, 7 of which were retained. The final criteria and their weights were as follows: maximum eosinophil count ≥1×109/L (+5), obstructive airway disease (+3), nasal polyps (+3), cytoplasmic antineutrophil cytoplasmic antibody (ANCA) or anti-proteinase 3-ANCA positivity (-3), extravascular eosinophilic predominant inflammation (+2), mononeuritis multiplex/motor neuropathy not due to radiculopathy (+1) and haematuria (-1). After excluding mimics of vasculitis, a patient with a diagnosis of small- or medium-vessel vasculitis could be classified as having EGPA if the cumulative score was ≥6 points. When these criteria were tested in the validation data set, the sensitivity was 85% (95% CI 77% to 91%) and the specificity was 99% (95% CI 98% to 100%).The 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis demonstrate strong performance characteristics and are validated for use in research.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
李健的粉丝团团长的应助被yj采纳,获得10
1秒前
panswiii完成签到,获得积分10
2秒前
2秒前
深情从灵完成签到 ,获得积分10
3秒前
七月发布了新的文献求助10
3秒前
勤奋冬灵发布了新的文献求助10
3秒前
孙兆楠发布了新的文献求助30
8秒前
10秒前
满意的柏柳完成签到 ,获得积分10
10秒前
石雨欣完成签到 ,获得积分10
10秒前
七月完成签到,获得积分10
12秒前
胡帅完成签到 ,获得积分10
14秒前
Hello的应助被猫猫小队长采纳,获得10
15秒前
冷艳招牌完成签到,获得积分10
15秒前
16秒前
大模型的应助被PziPzi采纳,获得10
16秒前
17秒前
huang完成签到,获得积分20
17秒前
爆米花的应助被莉莉丝采纳,获得10
17秒前
17秒前
uoe完成签到,获得积分10
18秒前
19秒前
19秒前
Cheney完成签到 ,获得积分10
19秒前
MIMIMOMO完成签到,获得积分10
19秒前
WwwJmmmm完成签到,获得积分10
19秒前
19秒前
小二郎的应助被孙兆楠采纳,获得10
20秒前
小马甲的应助被123456采纳,获得10
20秒前
20秒前
英俊的柏柳完成签到,获得积分20
20秒前
李爱国的应助被like采纳,获得30
21秒前
谨慎芷烟发布了新的文献求助20
21秒前
v0id的应助被lin采纳,获得10
21秒前
wodetaiyangLLL完成签到,获得积分10
22秒前
MIMIMOMO发布了新的文献求助10
23秒前
24秒前
知性的平卉完成签到 ,获得积分10
25秒前
25秒前
26秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Aspects of Post-SPE Phonology 2000
Nanocomposite Removal of Pesticides from Wastewater 1000
Rosenblum, Global Change Biology 800
Final Report for the 2-D Test of Model 901 Rotor and Wing Airfoils (BSWT 592) 528
Berberine regulates the TLR4 signaling pathway to suppress hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells 520
Organizational Behavior 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 物理 有机化学 化学工程 内科学 生物化学 复合材料 催化作用 心理学 细胞生物学 无机化学 电极 光电子学 人工智能
热门帖子
关注 科研通微信公众号,转发送积分 7895813
求助须知:如何正确求助?哪些是违规求助? 9404708
关于积分的说明 20865595
捐赠科研通 7498955
什么是DOI,文献DOI怎么找? 3359327
关于科研通互助平台的介绍 2497546
邀请新用户注册赠送积分活动 2388645